Reuters logo
BRIEF-Advanced Accelerator Applications receives complete response letter from FDA for Lutathera
December 21, 2016 / 12:28 PM / a year ago

BRIEF-Advanced Accelerator Applications receives complete response letter from FDA for Lutathera

Dec 21 (Reuters) - Advanced Accelerator Applications Sa

* Advanced Accelerator Applications receives complete response letter from FDA for Lutathera, an investigational treatment for neuroendocrine tumors

* Advanced Accelerator Applications - No additional clinical studies were requested in CRL and no comments at this time on other sections of NDA submission Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below